Association of circulating serum free bioavailable and total vitamin D with cathelicidin levels among active TB patients and household contacts
[ad_1]
Huang, S. J. et al. Vitamin D deficiency and the risk of tuberculosis: A meta-analysis. Drug Des. Dev. Therapy. 11, 91 (2017).
Acen, B. I. A., Bbuye, M., Patrick, K. D., Joloba, M. L. & Worodria, W. Hypovitaminosis D among newly diagnosed pulmonary TB patients and their household contacts in Uganda. Sci. Rep. 12(1), 1–8 (2022).
Nnoaham Kelechi, E. & Clarke, A. Low serum vitamin D levels and tuberculosis: A systematic review and meta-analysis. Int. J. Epidemiol. 37(1), 113–119 (2008).
Workineh, B. M. et al. Vitamin D deficiency among newly diagnosed tuberculosis patients and their household contacts: A comparative cross-sectional study. BMC Arch. Public Health 75, 25 (2017).
Roberts, K. F. H., Elliott, M. S. & Han, Z. Is there pandemic vitamin D deficiency in the black population? A review of evidence. Open Nutr. J. 9, 1 (2015).
Wu, H., Xiong, X., Zhu, M., Zhuo, K. & Cheng, D. Effects of vitamin D supplementation on the outcomes of patients with pulmonary tuberculosis: A systematic review and metaanalysis. BMC Pulm. Med. 18, 108 (2018).
Zerwekh, J. E. Blood biomarkers of vitamin D status. Am. J. Clin. Nutr. 87(4), 1087S-1091S (2008).
Tangoh, A. T. et al. Vitamin D status and its associated risk factors among adults in the southwest region of Cameroon. J. Nutr. Metab. 2018, 1 (2018).
Pereira, J. N., Chactoura, J., Nohra, F., Diogenes, M. E. & Bezerra, F. F. Free and bioavailable fractions of vitamin D: Association with maternal characteristics in Brazilian pregnant women. Hindawi J. Nutr. Metab. 9, 1 (2020).
Tsuprykov, O., Buse, C., Skoblo, R., Haq, A. & Hocher, B. Reference intervals for measured and calculated free 25-hydroxyvitamin D in normal pregnancy. J. Steroid Biochem. Mol. Biol. 181, 80–87 (2018).
Chun, E. P. B., Eric, S. O., Carrie, M. N., John, S. A. & Martin, H. Vitamin D and DBP: The free hormone hypothesis revisited. J. Steroid Biochem. Mol. Biol. 144, 132–137 (2014).
Tsuprykov, O., Buse, C., Skoblo, R. & Hocher, B. Comparison of free and total 25-hydroxyvitamin D in normal human pregnancy. J. Steroid Biochem. Mol. Biol. 190, 29–36 (2019).
Alzaman, N. S., Dawson-Hughes, B., Nelson, J., D’Alessio, D. & Pittas, A. G. Vitamin D status of black and white Americans and changes in vitamin D metabolites after varied doses of vitamin D supplementation. Am. J. Clin. Nutr. 104(1), 205–214 (2016).
Schwartz, J. B. et al. A comparison of measured and calculated free 25 (OH) vitamin D levels in clinical populations. J. Clin. Endocrinol. Metab. 99(5), 1631–1637 (2014).
Ishir, B. et al. Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients. Kidney Int. 82, 84–89 (2012).
Bikle, D. D. et al. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J. Clin. Endocrinol. Metab. 63(4), 954–959 (1986).
Haughton, M. A. & Mason, R. S. Immunonephelometric assay of vitamin D-binding protein. Clin. Chem. 38(9), 1796–1801 (1992).
Vijay, J. et al. Association of vitamin D deficiency and newly diagnosed pulmonary tuberculosis. Pulm. Med. 6, 1 (2021).
Rivas-Santiago, B. et al. Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis. Int. J. Antimicrob. Agents 41(2), 143–148 (2013).
Martineau, A. R. et al. Neutrophil-mediated innate immune resistance to mycobacteria. J. Clin. Investig. 117(7), 1988–1994 (2007).
Liu, P. T. et al. Toll-like receptor triggering of a vitamin D–mediated human antimicrobial response. Science 311, 1770 (2006).
Yamshchikov, A. V. et al. Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis. Am. J. Clin. Nutr. 92(3), 603–611 (2010).
Zhu, A., Kuznia, S. & Niedermaier, T. Distribution and determinants of vitamin D-binding protein, total, “non-bioavailable”, bioavailable, and free 25-hydroxyvitamin D concentrations among older adults. Nutrients 13, 39821 (2021).
Aloia, J. et al. Free 25 (OH)D and the vitamin D paradox in African Americans. J. Clin. Endocrinol. Metab. 100(9), 3356–3363 (2015).
Acen, B. I. A. et al. Impact of vitamin D status and cathelicidin antimicrobial peptide on adults with active pulmonary TB globally: A systematic review and meta-analysis. PLoS ONE 16(6), e0252762 (2021).
Kwon, B.-S. et al. A prospective cohort study of bioavailable 25-hydroxyvitamin D levels as a marker of vitamin d status in nontuberculous mycobacterial pulmonary disease. Nutrients 13(8), 2524 (2021).
Dhaliwal, R. et al. The relationship of physical performance and osteoporosis prevention with vitamin D in older African Americans (PODA). Contemp. Clin. Trials 65, 39–45 (2018).
Yang, B. et al. Significance of LL-37 on immunomodulation and disease outcome. BioMed Res. Int. 2020, 8349712 (2020).
Bhan, I. et al. Circulating levels of 25-hydroxyvitamin D and human cathelicidin in healthy adults. J. Allergy Clin. Immunol. 127(5), 1302–1304 (2011).
Johnsen, M. S. et al. Serum free and bio-available 25-hydroxyvitamin D correlate better with bone density than serum total 25-hydroxyvitamin D. Scand. J. Clin. Lab. Investig. 74(3), 177–183 (2014).
Fang, A. P. et al. Serum bioavailable, rather than total, 25-hydroxyvitamin D levels are associated with hepatocellular carcinoma survival. Hepatology 72(1), 169–182 (2020).
Yu, C. et al. Serum bioavailable and free 25-hydroxyvitamin D levels, but not its total level, are associated with the risk of mortality in patients with coronary artery disease. Circ. Res. 123(8), 996–1007 (2018).
Bikle, S. Vitamin D binding protein, total and free vitamin D levels in different physiological and pathophysiological conditions. Front. Endocrinol. 10, 317 (2019).
Kistan, J. et al. Pulmonary TB: Varying radiological presentations in individuals with HIV in Soweto, South Africa. Trans. R. Soc. Trop. Med. Hyg. 111(3), 132–136 (2017).
Yousefzadeh, S. S. & Wang, X. Vitamin D binding protein impact on 25-hydroxyvitamin D levels under different physiologic and pathologic conditions. Int. J. Endocrinol. 2014, 1 (2014).
Karcıoğlu Batur, L. et al. Vitamin-d binding protein gene polymorphisms and serum 25-hydroxyvitamin-d in a Turkish population. Metabolites 11(10), 696 (2021).
Mogire, R. M. et al. Prevalence of vitamin D deficiency in Africa: A systematic review and meta-analysis. Lancet Glob. Health 8, 134–142 (2019).
Elenius, V. et al. The relationship of serum vitamins A, D, E and LL-37 levels with allergic status, tonsillar virus detection and immune response. PLoS ONE 12(2), e0172350 (2017).
Maurya, V. K. & Aggarwal, M. Factors influencing the absorption of vitamin D in GIT: An overview. J. Food Sci. Technol. 54(12), 3753–3765 (2017).
Maurya, V. K. & Aggarwal, M. Factors influencing the absorption of vitamin D in GIT: An overview. J. Food Sci. Technol. 54, 3753–3765 (2017).
Iqbal, N. et al. Interplay of chemo attractant peptides (cathelicidin and chemerin) with vitamin-D in patients with pulmonary tuberculosis. Br. J. Med. Med. Res. 7(7), 611 (2015).
Ashenafi, M. et al. Vitamin D (3) status and the association with human cathelicidin expression in patients with different clinical forms of active tuberculosis. Nutrients 10(6), 1 (2018).
Selvaraj, P., Prabhu Anand, S., Harishankar, M. & Alagarasu, K. Plasma 1,25 dihydroxy vitamin D3 level and expression of vitamin D receptor and cathelicidin in pulmonary tuberculosis. J. Clin. Immunol. 29, 470–478 (2009).
Coşar, E. et al. The relation of serum vitamin D and cathelicidin levels in recurrent lower respiratory tract infections in preschool children. J. Pediatr. Infect./Cocuk Enfeksiyon Dergisi. 12(2), 1 (2018).
Quraishi, S. A. et al. Effect of cholecalciferol supplementation on vitamin D status and cathelicidin levels in sepsis: A randomized, placebo-controlled trial. Crit. Care Med. 43(9), 1928 (2015).
Bhan, I. Vitamin D binding protein and bone health. Int. J. Endocrinol. 561214, 5 (2014).
[ad_2]
Source link
